BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 29277560)

  • 1. Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.
    Panés J; García-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Diez MC; Tagarro I; Leselbaum A; Danese S;
    Gastroenterology; 2018 Apr; 154(5):1334-1342.e4. PubMed ID: 29277560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.
    Panés J; García-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Leselbaum A; Danese S;
    Lancet; 2016 Sep; 388(10051):1281-90. PubMed ID: 27477896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.
    Molendijk I; Bonsing BA; Roelofs H; Peeters KC; Wasser MN; Dijkstra G; van der Woude CJ; Duijvestein M; Veenendaal RA; Zwaginga JJ; Verspaget HW; Fibbe WE; van der Meulen-de Jong AE; Hommes DW
    Gastroenterology; 2015 Oct; 149(4):918-27.e6. PubMed ID: 26116801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Darvadstrocel for Complex Perianal Fistulas in Japanese Adults with Crohn's Disease: A Phase 3 Study.
    Furukawa S; Mizushima T; Nakaya R; Shibata M; Yamaguchi T; Watanabe K; Futami K
    J Crohns Colitis; 2023 Apr; 17(3):369-378. PubMed ID: 36149832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial.
    de la Portilla F; Alba F; García-Olmo D; Herrerías JM; González FX; Galindo A
    Int J Colorectal Dis; 2013 Mar; 28(3):313-23. PubMed ID: 23053677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn's Disease.
    Dige A; Hougaard HT; Agnholt J; Pedersen BG; Tencerova M; Kassem M; Krogh K; Lundby L
    Gastroenterology; 2019 Jun; 156(8):2208-2216.e1. PubMed ID: 30772343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease-A prospective nationwide multicenter cohort study.
    Dawoud C; Widmann KM; Czipin S; Pramhas M; Scharitzer M; Stift A; Harpain F; Riss S
    Wien Klin Wochenschr; 2024 May; 136(9-10):289-294. PubMed ID: 37823920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas.
    Barnhoorn MC; Wasser MNJM; Roelofs H; Maljaars PWJ; Molendijk I; Bonsing BA; Oosten LEM; Dijkstra G; van der Woude CJ; Roelen DL; Zwaginga JJ; Verspaget HW; Fibbe WE; Hommes DW; Peeters KCMJ; van der Meulen-de Jong AE
    J Crohns Colitis; 2020 Jan; 14(1):64-70. PubMed ID: 31197361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis.
    Cheng F; Huang Z; Li Z
    Tech Coloproctol; 2019 Jul; 23(7):613-623. PubMed ID: 31286287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cell therapy for Crohn's perianal fistula-a real-world experience.
    White I; Yanai H; Avni I; Slavin M; Naftali T; Tovi S; Dotan I; Wasserberg N
    Colorectal Dis; 2024 Jan; 26(1):102-109. PubMed ID: 38095303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial.
    Panés J; Bouma G; Ferrante M; Kucharzik T; Nachury M; de la Portilla de Juan F; Reinisch W; Selvaggi F; Tschmelitsch J; Brett NR; Ladouceur M; Binek M; Hantsbarger G; Campbell-Hill S; Karki C; Buskens C
    Inflamm Bowel Dis; 2022 Nov; 28(11):1737-1745. PubMed ID: 35099555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Zhu M; Xu X; Feng Q; Cui Z; Wang T; Yan Y; Ran Z
    Dig Dis Sci; 2021 May; 66(5):1658-1668. PubMed ID: 32524415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic adipose-derived stem cells for the treatment of perianal fistula in Crohn's disease: a pilot clinical trial.
    Park KJ; Ryoo SB; Kim JS; Kim TI; Baik SH; Kim HJ; Lee KY; Kim M; Kim WH
    Colorectal Dis; 2016 May; 18(5):468-76. PubMed ID: 26603576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease.
    Kotze PG; Spinelli A; Warusavitarne J; Di Candido F; Sahnan K; Adegbola SO; Danese S
    Drugs Today (Barc); 2019 Feb; 55(2):95-105. PubMed ID: 30816884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial.
    Meima-van Praag EM; van Rijn KL; Wasmann KATGM; Snijder HJ; Stoker J; D'Haens GR; Gecse KB; Gerhards MF; Jansen JM; Dijkgraaf MGW; van der Bilt JDW; Mundt MW; Spinelli A; Danese S; Bemelman WA; Buskens CJ
    Lancet Gastroenterol Hepatol; 2022 Jul; 7(7):617-626. PubMed ID: 35427495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase IB/IIA Study of Allogeneic, Bone Marrow-derived, Mesenchymal Stem Cells for the Treatment of Refractory Ileal-anal Anastomosis and Peripouch Fistulas in the Setting of Crohn's Disease of the Pouch.
    Lightner AL; Reese J; Ream J; Nachand D; Jia X; Pineiro AO; Dadgar N; Steele S; Hull T
    J Crohns Colitis; 2023 Apr; 17(4):480-488. PubMed ID: 36322714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Darvadstrocel: A Review in Treatment-Refractory Complex Perianal Fistulas in Crohn's Disease.
    Scott LJ
    BioDrugs; 2018 Dec; 32(6):627-634. PubMed ID: 30298387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).
    Dewint P; Hansen BE; Verhey E; Oldenburg B; Hommes DW; Pierik M; Ponsioen CI; van Dullemen HM; Russel M; van Bodegraven AA; van der Woude CJ
    Gut; 2014 Feb; 63(2):292-9. PubMed ID: 23525574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous fat graft injections for the treatment of perianal fistulas in Crohn's disease: a systematic review and single-arm meta-analysis.
    De Gregorio M; Tiang T; Lee T; Stellingwerf ME; Singh S; Thompson AJ; D'Souza B; Ding NS;
    ANZ J Surg; 2023 May; 93(5):1162-1168. PubMed ID: 36658773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.